SUNRUN INC (RUN)

US86771W1053 - Common Stock

10.1  +0.23 (+2.33%)

After market: 10.1199 +0.02 (+0.2%)

Fundamental Rating

2

Overall RUN gets a fundamental rating of 2 out of 10. We evaluated RUN against 88 industry peers in the Electrical Equipment industry. RUN has a bad profitability rating. Also its financial health evaluation is rather negative. RUN is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year RUN has reported negative net income.
RUN had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: RUN reported negative net income in multiple years.
RUN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a decent Return On Assets value of -1.73%, RUN is doing good in the industry, outperforming 62.50% of the companies in the same industry.
RUN has a better Return On Equity (-7.25%) than 61.36% of its industry peers.
Industry RankSector Rank
ROA -1.73%
ROE -7.25%
ROIC N/A
ROA(3y)-2.48%
ROA(5y)-1.64%
ROE(3y)-9.79%
ROE(5y)-5.9%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

RUN has a Gross Margin (13.02%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of RUN has declined.
RUN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.06%
GM growth 5Y-24.6%

More info and screens

1

2. Health

2.1 Basic Checks

RUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
RUN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for RUN has been increased compared to 5 years ago.
The debt/assets ratio for RUN is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.01, we must say that RUN is in the distress zone and has some risk of bankruptcy.
RUN has a Altman-Z score (0.01) which is comparable to the rest of the industry.
A Debt/Equity ratio of 2.33 is on the high side and indicates that RUN has dependencies on debt financing.
The Debt to Equity ratio of RUN (2.33) is worse than 80.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF N/A
Altman-Z 0.01
ROIC/WACCN/A
WACC5.96%

2.3 Liquidity

RUN has a Current Ratio of 1.47. This is a normal value and indicates that RUN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of RUN (1.47) is worse than 69.32% of its industry peers.
A Quick Ratio of 1.15 indicates that RUN should not have too much problems paying its short term obligations.
The Quick ratio of RUN (1.15) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.15

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.91% over the past year.
The Revenue for RUN has decreased by -13.46% in the past year. This is quite bad
The Revenue has been growing by 24.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)66.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.48%
Revenue 1Y (TTM)-13.46%
Revenue growth 3Y34.82%
Revenue growth 5Y24.35%
Sales Q2Q%-4.62%

3.2 Future

Based on estimates for the next years, RUN will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.39% on average per year.
Based on estimates for the next years, RUN will show a quite strong growth in Revenue. The Revenue will grow by 9.88% on average per year.
EPS Next Y94.2%
EPS Next 2Y37.73%
EPS Next 3Y24.29%
EPS Next 5Y15.39%
Revenue Next Year-8.78%
Revenue Next 2Y1.95%
Revenue Next 3Y5.8%
Revenue Next 5Y9.88%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RUN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as RUN's earnings are expected to grow with 24.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.73%
EPS Next 3Y24.29%

More info and screens

0

5. Dividend

5.1 Amount

RUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUNRUN INC

NASDAQ:RUN (12/23/2024, 8:00:01 PM)

After market: 10.1199 +0.02 (+0.2%)

10.1

+0.23 (+2.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners117.14%
Inst Owner Change-3.9%
Ins Owners2.5%
Ins Owner Change-1.46%
Market Cap2.27B
Analysts72.9
Price Target18.72 (85.35%)
Short Float %22.03%
Short Ratio5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)54.58%
Min EPS beat(2)-157.51%
Max EPS beat(2)266.67%
EPS beat(4)2
Avg EPS beat(4)-81.56%
Min EPS beat(4)-448.61%
Max EPS beat(4)266.67%
EPS beat(8)4
Avg EPS beat(8)-304.02%
EPS beat(12)6
Avg EPS beat(12)-221.36%
EPS beat(16)8
Avg EPS beat(16)-151.91%
Revenue beat(2)1
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-5.73%
Max Revenue beat(2)0.68%
Revenue beat(4)1
Avg Revenue beat(4)-2.95%
Min Revenue beat(4)-5.73%
Max Revenue beat(4)0.68%
Revenue beat(8)3
Avg Revenue beat(8)-0.99%
Revenue beat(12)7
Avg Revenue beat(12)3.88%
Revenue beat(16)11
Avg Revenue beat(16)4.15%
PT rev (1m)-18.47%
PT rev (3m)-16.08%
EPS NQ rev (1m)7.57%
EPS NQ rev (3m)30.92%
EPS NY rev (1m)-95.18%
EPS NY rev (3m)-36.13%
Revenue NQ rev (1m)-0.68%
Revenue NQ rev (3m)-7.28%
Revenue NY rev (1m)-1.14%
Revenue NY rev (3m)-2.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.11
P/FCF N/A
P/OCF N/A
P/B 0.43
P/tB 1.05
EV/EBITDA N/A
EPS(TTM)-1.82
EYN/A
EPS(NY)-0.76
Fwd EYN/A
FCF(TTM)-14.21
FCFYN/A
OCF(TTM)-2.78
OCFYN/A
SpS9.07
BVpS23.53
TBVpS9.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.73%
ROE -7.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.02%
FCFM N/A
ROA(3y)-2.48%
ROA(5y)-1.64%
ROE(3y)-9.79%
ROE(5y)-5.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.06%
GM growth 5Y-24.6%
F-Score3
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 426.35%
Cap/Sales 125.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 1.15
Altman-Z 0.01
F-Score3
WACC5.96%
ROIC/WACCN/A
Cap/Depr(3y)456.97%
Cap/Depr(5y)443.83%
Cap/Sales(3y)102.26%
Cap/Sales(5y)101.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.48%
EPS Next Y94.2%
EPS Next 2Y37.73%
EPS Next 3Y24.29%
EPS Next 5Y15.39%
Revenue 1Y (TTM)-13.46%
Revenue growth 3Y34.82%
Revenue growth 5Y24.35%
Sales Q2Q%-4.62%
Revenue Next Year-8.78%
Revenue Next 2Y1.95%
Revenue Next 3Y5.8%
Revenue Next 5Y9.88%
EBIT growth 1Y21.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year110.25%
EBIT Next 3Y30.13%
EBIT Next 5Y19.53%
FCF growth 1Y-13.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.43%
OCF growth 3YN/A
OCF growth 5YN/A